The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis

[1]  G. Shelton,et al.  Risk Factors and Outcomes in Cats with Acquired Myasthenia Gravis (2001–2012) , 2015, Journal of veterinary internal medicine.

[2]  A. Mammen,et al.  The co-existence of myasthenia gravis in patients with myositis: a case series. , 2014, Seminars in arthritis and rheumatism.

[3]  Honghua Li,et al.  Fusion protein of single-chain variable domain fragments for treatment of myasthenia gravis , 2014, Neural regeneration research.

[4]  T. Konishi.  [Myasthenia gravis with anti-acetylcholine receptor antibody or anti-muscle specific kinase antibody]. , 2011, Brain and nerve = Shinkei kenkyu no shinpo.

[5]  D. Sanders,et al.  Anti‐musk antibody myasthenia gravis: Clinical findings and response to treatment in two large cohorts , 2011, Muscle & nerve.

[6]  N. Gilhus,et al.  Guidelines for treatment of autoimmune neuromuscular transmission disorders , 2006, European journal of neurology.

[7]  D. Hilton‐Jones,et al.  When the patient fails to respond to treatment: myasthenia gravis , 2007, Practical Neurology.

[8]  A. Lefvert,et al.  Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[9]  Y. Parman,et al.  Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis , 2007, Neurology.

[10]  Y. Abe,et al.  Induction of myasthenia by immunization against muscle-specific kinase. , 2006, The Journal of clinical investigation.

[11]  M. D. de Baets,et al.  The features of myasthenia gravis with autoantibodies to MuSK , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[12]  N. Maggiano,et al.  Thymus changes in anti-MuSK-positive and -negative myasthenia gravis. , 2005, Neurology.

[13]  A. Vincent,et al.  Clinical comparison of muscle‐specific tyrosine kinase (MuSK) antibody‐positive and ‐negative myasthenic patients , 2004, Muscle & nerve.

[14]  C. Legay,et al.  MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction , 2004, The Journal of cell biology.

[15]  J. Téllez-Zenteno,et al.  Response of thymectomy: clinical and pathological characteristics among seronegative and seropositive myasthenia gravis patients , 2004, Acta neurologica Scandinavica.

[16]  M. Schluep,et al.  The thymus in seronegative myasthenia gravis patients , 1991, Journal of Neurology.

[17]  P. Tonali,et al.  Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. , 2003, Brain : a journal of neurology.

[18]  A. Vincent,et al.  Clinical aspects of MuSK antibody positive seronegative MG , 2003, Neurology.

[19]  A. Vincent,et al.  Unravelling the pathogenesis of myasthenia gravis , 2002, Nature Reviews Immunology.

[20]  A. Vincent,et al.  Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies , 2001, Nature Medicine.

[21]  D B Sanders,et al.  Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. , 2000, Neurology.

[22]  R. Barohn,et al.  Myasthenia gravis , 2000, Neurology.

[23]  J. Lindstrom.  Acetylcholine receptors and myasthenia , 2000, Muscle & nerve.

[24]  H. Müller-Hermelink,et al.  Pathogenesis of myasthenia gravis , 1997, Virchows Archiv.

[25]  J. Howard,et al.  Seronegative myasthenia gravis , 1988, Neurology.

[26]  A. Vincent,et al.  Seronegative Myasthenia Gravis: Evidence for Plasma Factor(s) Interfering with Acetylcholine Receptor Function a , 1993, Annals of the New York Academy of Sciences.

[27]  S. Nagataki,et al.  Treatment of myasthenia gravis: a comparison of the natural course and current therapies. , 1993, The Tohoku journal of experimental medicine.

[28]  J. Oger,et al.  Seronegative generalized myasthenia gravis , 1992, Neurology.

[29]  L. Elveback,et al.  Clinical Correlations of Antibodies That Bind, Block, or Modulate Human Acetylcholine Receptors in Myasthenia Gravis a , 1987, Annals of the New York Academy of Sciences.

[30]  A. Vincent,et al.  Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. , 1985, Journal of neurology, neurosurgery, and psychiatry.

[31]  G. Tridente.  Immunopathology of the human thymus. , 1985, Seminars in hematology.

[32]  J. Bach,et al.  Anti‐AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis , 1984, Neurology.

[33]  A. Vincent,et al.  4 Acetylcholine receptors and myasthenia gravis , 1983 .

[34]  S. Self,et al.  Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. , 1982, The New England journal of medicine.

[35]  Thomas Stretch Dowse,et al.  MUSCLE AND NERVE , 1903 .